Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Piramal Pharma Limited has filed a regulatory notification informing stock exchanges (BSE and NSE) that the transcript of their earnings conference call held on 29th April 2026 is now available on the company's website. The conference call covered the audited financial results for Q4 and the full year ended 31st March 2026. This filing is a standard compliance requirement under SEBI LODR regulations. The actual transcript content, including any management commentary, financial performance details, or forward-looking statements, is not included in this filing — investors must access the full transcript separately on the company website. No specific financial figures, guidance, or operational details are disclosed in this notification.
This filing is informational only and does not provide any new investment-relevant information. Shareholders interested in the company's Q4/FY2026 performance will need to review the full transcript on the company website for details on management's outlook and discussion.